Investors / United Kingdom / SCI Ventures
SCI Ventures
Venture capital · London, United Kingdom · Europe
SCI Ventures is a specialist venture fund that invests in early-stage companies developing treatments and cures for paralysis, starting with spinal cord injury. It is backed by six research foundations addressing spinal cord injury in the US, UK and EU, and its initial operating costs are met by the Christopher and Dana Reeve Foundation.
Invests inHealthcare & Biotech
In its own wordsparalysisspinal cord injuryneurosciencebiotechtherapeuticsregenerative medicine
Your fit with SCI Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSCI Ventures lists 10 checked portfolio companies on its own site and is named in 3 funding rounds, 1 of them as lead. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (75%), Fintech (8%) and Crypto & Web3 (8%). 38% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, ARK Venture Fund and Aurum Venture Partners.
Counts come from funding rounds that name SCI Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not SCI Ventures' whole history. Rounds on record name 3 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 1 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 92th | 20% of companies confirmed by a round |
| Sector focus | 93th | 75% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Creative Destruction Lab | 2 |
| ARK Venture Fund | 1 |
| Aurum Venture Partners | 1 |
| Axial | 1 |
| B Capital | 1 |
| BGF | 1 |
| Carao Ventures | 1 |
| Civilization Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 75% | 15% |
| Fintech | 8% | 12% |
| Crypto & Web3 | 8% | 1% |
| Consumer | 8% | 3% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare SCI Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with SCI Ventures| Date | Company | Stage |
|---|---|---|
| 9 Sept 2026 | Round | |
| 5 Nov 2025 | Round Led | |
| 29 Aug 2025 | Series B |
Round details for SCI Ventures
Amounts, full round histories and every co-investor in SCI Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Augmental develops and sells a custom-fit mouthpiece that enables hands-free control of computers and other devices. | Healthcare & BiotechConsumer | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Cyllene Therapeutics is developing a powerful DNA medicine platform to treat chronic diseases | Healthcare & Biotech | Portfolio page | ||
| Healx builds an AI-native rare disease pharma | Healthcare & Biotech | Portfolio page | ||
| NervGen develops first-in-class neuroreparative therapies that target the biological barriers to neural repair | Healthcare & Biotech | Portfolio page | ||
| The company develops therapies, including spinal cord stimulation and brain-computer interface technology, for people with spinal cord injury and Parkinson's disease. | Healthcare & Biotech | Portfolio page | ||
| OrangeX allows users to trade crypto perpetuals and spot | FintechCrypto & Web3 | Aug 2025Series B | Funding round | |
| Precision Neuroscience develops brain-computer interfaces to help people with paralysis operate digital devices using only their thoughts | Healthcare & Biotech | Nov 2025Round | Page + round | |
| Sania Therapeutics harnesses the nervous system to treat a broad range of prevalent and underserved disease areas with precision therapies. | Healthcare & Biotech | Portfolio page | ||
| Vianautis Bio is transforming cell and gene therapy with a versatile, non-viral, targeted polymer-based nanovesicles delivery system | Healthcare & Biotech | Sept 2026Round | Page + round |
About this data
site last read 5 Nov 2026- Site
- sciventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 29 Aug 2025
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get SCI Ventures' profile as data
Pull SCI Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/sciventures.com
# also
GET /v1/firms/sciventures.com/portfolio
GET /v1/firms/sciventures.com/coinvestors
GET /v1/firms/sciventures.com/news